Latest News and Press Releases
Want to stay updated on the latest news?
-
Hyloris Pharmaceuticals Broadens Pipeline with a Proprietary Intranasal Product Candidate of a TRPV11 agonist (HY-083) for Idiopathic Rhinitis Hyloris targets a condition that affects up to 7% of...
-
CEO will appear on the On The Move show to discuss Company’s technology as a high-tech alternative to vaping devices, why the GCANRx patch is safer, and what’s in the pipeline for the future. ...